![FDA approves medicine for treatment of deep vein thrombosis](https://www.mcknights.com/wp-content/uploads/sites/5/2018/07/xarelto_178333.jpg)
The Food and Drug Administration has approved Janssen Pharmaceuticals, Inc.’s Xarelto (rivaroxaban ). Xarelto is intended for the treatment of deep vein thrombosis (DVT). If all or part of a DVT breaks off, it can travel to and lodge in the lungs, and can lead to potentially life-threatening consequences.